CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


18-February-2014
Introducing  Clozapine N-oxide, Cerilliant's latest atypical antipsychotic metabolite Certified Spiking Solution®.

Clozapine N-oxide, 100 ug/mL, C-125
100 µg/mL in Methanol

Clozapine N-oxide is the main metabolite of clozapine, an atypical antipsychotic prescribed for the treatment of schizophrenia and as an off-label treatment for bipolar disorder. This Certified Spiking Solution® is suitable for use as starting material in calibrators or controls for a variety of LC/MS or GC/MS testing applications from forensic analysis and clinical toxicology to urine drug testing.

Coming soon, Cerilliant will introduce Certified Spiking Solutions® of the following antipsychotics:

Hydroxyiloperidone (H-104)
Lurasidone-D8 (L-035)



Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn